Innovation in Personalized Medicine: processes and management

Thank you for reading this post, don't forget to subscribe!

Marta Villanueva, general director of the IDIS Foundation.

“The idiosyncrasy of private provision and insurance is based on customization and the determined commitment to innovation disruptive, which encompasses processes and forms of management”. In other words, individualized medicine and the latest technologies are intrinsic values in private healthcare and, with these words, from the Institute for the Development and Integration of Health (IDIS Foundation) they demand a role in the Personalized Medicine Plan and Accuracy of 5P for the National Health System (SNS) announced by the Minister of Health, Carolina Darias.

In this sense, the Government of Spain has stated that the objective of this plan is for the public health centers are updated and they can use “genetic testing of great value for the diagnosis and prognosis of diseases of great health and social impact”. These tools would be used above all for diagnose rare pathologies or oncologywhich would generate greater safety and efficiency when using targeted therapies.

Despite not having named the public-private collaboration In this initiative, the private healthcare sector has raised its voice and explained that the medicine of the 5 or 6Ps (personalization, precision, prediction, prevention, participation and population character) requires “a firm commitment to innovation in its broadest sense, including that which refers to processes, procedures and forms of management”.

In fact, to improve these processes and control the failures that may occur in the system, it is essential that the measurement has a gap in medicine. For this reason, one of the aspects that privately owned healthcare champions is the improvement of competitivenesswhich, in his view, “requires quantitative and qualitative results quantifiable and measurable.

On the other hand, if the Administration wants focus on patients In order to offer more individualized treatments, it will be essential that have the best technology. “The private sector is at the forefront of everything that the private sector is going to offer us. digital technology and what will contribute to the development of new technologies of diagnosis, treatment and prevention”, expose from IDIS.

Private interoperability project

Technology is in the spotlight of the private sector. His latest challenge in this regard is the interoperability project and continuity of care. An initiative in which the public health medical record with the private data.

“It’s going to be big patient benefitsfor the professional and for the health system itself since the patient, owners of their own health data, will be able to navigate the system with them, thus being able to make use of them according to their own criteria, initiative and will”, they point out.

Among its advantages is the reduction in the consumption of health resources, the elimination of duplications and diagnostic tests or the best patient monitoring, among others. Undoubtedly, the shared medical history is one of the great challenges of the Spanish health system and due to its characteristics it could be very useful in this plan that is about to be finalized. “This project for its structure, scope, route and application character undoubtedly impacts on all aspects of medicine of the 5P or the 6P”, they conclude from IDIS.

Although it may contain statements, data or notes from health institutions or professionals, the information contained in Redacción Médica is edited and prepared by journalists. We recommend to the reader that any health-related questions be consulted with a health professional.

Related Articles

Back to top button